Irinotecan and thalidomide in metastatic golorectal cancer

ONCOLOGY

Volumn 14, Issue 12 SUPPL. 13, 2000, Pages 29-32

  Govindarajan, Rangaswamy ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; DRUG DERIVATIVE; IRINOTECAN; THALIDOMIDE;

ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL TRIAL; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; PILOT STUDY;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PILOT PROJECTS; THALIDOMIDE;

EID: 0034568351     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Moertel CG: Large bowel. Cancer Medicine 1497, 1973.
2. Carter SK: Large-bowel cancer: The current status of treatment. J Natl Cancer Inst 56:3-10, 1976.
3. Rothenberg ML, Eckardt JR, Kuhn JG, et al: Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol 14(4):1128-1135, 1996.
4. Pitot HC, Wender DB, O'Connell MJ, et al: Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J Clin Oncol 15(8):2910-2919, 1997.
5. Rougier P, Van Cutsem E, Bajetta E, et al: Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure patients with metastatic colorectal cancer. Lancet 352:1407-1412, 1998.
6. Cunningham D, Pyrhonen S, James R, et al: Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 352:1413-1418, 1998.
7. Vasiliauskas EA, Kam LY, Abreau-Martin MT, et al: An open label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology 117:1278-1287, 1999.
8. Ehrenpreis ED, Kane SV, Cohen LB, et al: Thalidomide therapy for patients with refractory Crohn's disease: An open label trial. Gastroenterology 117:1271-1277, 1999.